{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph.\n\nParagraph: X - linked dilated cardiomyopathy ( XLDCM ) is a clinical phenotype of dystrophinopathy which is characterized by preferential myocardial involvement without any overt clinical signs of skeletal myopathy .\n\nLet's think step by step."},
    {"role": "assistant", "content": "1. X-linked dilated cardiomyopathy (XLDCM): This is the primary disease entity mentioned in the paragraph. It is a type of cardiomyopathy, which is a heart disease characterized by the dilatation of the heart chambers. In this case, it is specifically X-linked, meaning it is passed down through the X chromosome."},
    {"role": "user", "content": "Please remove irrelevant entities and only keep the entities that clearly refer to Disease."},
    {"role": "assistant", "content": "1. X-linked dilated cardiomyopathy (XLDCM)\n\nThis is the only disease entity mentioned in the paragraph. The other term, \"dystrophinopathy,\" is a broader category of genetic disorders that includes various forms of muscular dystrophies, some of which can also affect the heart (such as XLDCM). However, in the context of the paragraph, it is not explicitly stated that the form of dystrophinopathy being discussed is a disease entity itself, but rather a category that includes XLDCM. Therefore, it is not included in the list of identified disease entities."},
    {"role": "user", "content": "Please present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease          |\n|-----------------|\n| X-linked dilated cardiomyopathy (XLDCM) |"}
  ]
}